Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (5): 695-698    DOI: 10.12891/ceog4360.2019
Original Research Previous articles | Next articles
Relationship between serum progesterone concentrations and pregnancy rates in hormone replacement treatment-frozen embryo transfer using progesterone vaginal tablets
Shun Akaeda1, *(), Daiki Kobayashi2, Kyoko Shioda1, Mikio Momoeda1
1Department of Integrated Women's Health, St. Luke's International Hospital, Tokyo, Japan
2Division of General Internal Medicine, Department of Medicine St. Luke's International Hospital, Tokyo, Japan
Download:  PDF(348KB)  ( 241 ) Full text   ( 12 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

In assisted reproductive technology (ART), hormone replacement treatment embryo transfer (HRT-ET) is common. However, the appropriate serum progesterone concentration is not well known in the case of transvaginal progesterone administration. The purpose of the current study is to investigate the relationship between serum progesterone concentration and pregnancy rate in HRT-ET using progesterone vaginal tablets. This is a retrospective cohort study, the authors investigated all patients who underwent HRT-ET at this hospital for the first time from September 1, 2010 to September 30, 2015. A total of 227 cycles were performed in all 123 patients who underwent HRT-ET. In the total 123 cycles of first time HRT-ET, 32 cycles (26.0%) developed a pregnancy. The results of the multivariate analysis indicated that the patient’s age, embryo grade, serum estradiol concentration, and progesterone concentration had significant differences in relation to the pregnancy rate (p < 0.05). The latter rate tends to be lower when the serum progesterone concentration is less than 5 or more than 15 ng/ml. Therefore, the authors suggest that the appropriate serum progesterone concentration ranges from 5 to 15 ng/ml in HRT-ET using progesterone vaginal tablets.

Key words:  Progesterone      Embryo transfer      Pregnancy rate      Vaginal progesterone tablet      Hormone replacement therapy     
Published:  10 October 2019     
*Corresponding Author(s):  SHUN AKAEDA     E-mail:  shakaeda-tky@umin.ac.jp

Cite this article: 

Shun Akaeda, Daiki Kobayashi, Kyoko Shioda, Mikio Momoeda. Relationship between serum progesterone concentrations and pregnancy rates in hormone replacement treatment-frozen embryo transfer using progesterone vaginal tablets. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 695-698.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4360.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I5/695

[1] Mahvash Zargar, Razieh Pazhouhanfar, Mahin Najafian, Parastoo Moradi Choghakabodi. Effects of intrauterine autologous platelet-rich plasma infusions on outcomes in women with repetitive in vitro fertilization failures: a prospective randomized study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 179-184.
[2] Sh. Gaafar, T. Hanafy, S. El Morshedy, H. Mansour. Effect of extended embryo culture after thawing on clinical pregnancy rate[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 764-768.
[3] J.H. Check, A. DiAntonio, D.L. Check, M.P. Dougherty, G. Diantonio. A study to determine if estrogen (E) is needed to induce de novo progesterone (P) receptors on gamma/delta t cells as evidenced by determining the degree of rise of progesterone induced blocking factor (PIBF) following P exposure in males[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 419-420.
[4] T. Hasegawa, K. Nakagawa, R. Sugiyama, N. Kuji, H. Nishi. Separate transfer of two frozen-thawed embryos reduces multiple gestations in assisted reproductive technology[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 215-219.
[5] E. Kadour-Peero, S. Khoury, J. Awad, L. Shpritz, L. Chen-Konak, C. Shechner, L. Saiegh. Determination of estradiol and progesterone concentrations in human scalp hair[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 268-271.
[6] J.D. Jaremek, D.R. Chinniah, A. Słopień, P. Rynio, R. Słopień. Menopausal depression - state of art[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 859-861.
[7] R. Csorba, P. Tsikouras, A. Bothou, S. Zervoudis, G. Iatrakis, X. Anthoulaki, D. Deuteraiou, A. Chalkidou, G. F. von Tempelhoff. Air travel during pregnancy: an update review and practical recommendation[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 862-866.
[8] E.G. Aydeniz, U. Sari, T.U.K. Dilek. Pregnancy success rate at recurrent implantation failure patients after hysteroscopic endometrial injury: preliminary study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 709-712.
[9] P. Bakas, M. Simopoulou, P. Panagopoulos, N. Salakos, Ch. Siristatidis. Luteal phase progesterone and estradiol concentrations and their relation to the outcome of IVF/ICSI cycles with controlled ovarian stimulation[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 727-730.
[10] D. Summers, J.H. Check, R. Cohen, J.K. Choe. A live normal baby is possible despite exposure of a cleaving embryo in culture to extensive smoke and heat from a raging fire and exposure to chemicals used to extinguishing the fire[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 646-647.
[11] U. Indraccolo, G. Corona, M. Bonito, S.R. Indraccolo, E. Ferrazzi, R. Di Iorio. Selective medical treatment of heterotopic interstitial pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 656-657.
[12] J.H. Check, C. Dietterich, M. Lowney, V. Sapoznikov, R. Difilippo, J. Giangreco, K. Clarkson. Adjusting progesterone (P) dosage to compensate for a non-homogeneous hyperechogenic (HH) echo pattern three days after embryo transfer[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 356-358.
[13] J.H. Check, J. Liss, D. Check. The beneficial effect of luteal phase support on pregnancy rates in women with unexplained infertility[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 447-449.
[14] J.H. Check, M.P. Dougherty. Use of sympathomimetic amines to correct premenstrual urticaria and anaphylaxis[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 309-312.
[15] Chunjuan Shen, Liping Wang, Xiaojie Wu, Shuhui Mao, Chunxia Fang. The relationship between vitamin D and IVF: a systematic review and meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 12-15.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[5] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[6] George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105 .
[7] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[8] . SELF-ASSESSMENT POST-TEST[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 51 -52 .
[9] Alice K. Jacobs. Gender Differences in Coronary Revascularization: Does Age Make a Difference?[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 68 -70 .
[10] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .